Editor's Summaries of the Articles Published in This Issue of Precision Medicine Communications

Abstract

In this issue, Anum and colleagues have reported evidence-based prioritization and scoring of genomic loci interacting with pioglitazone therapeutic response in diabetic patients; Hasan and colleagues designed a study to determine the association of CP2C19*2 loss of function polymorphism with acute coronary syndrome patients receiving Clopidogrel, Zaheer, et al., reviewed escitalopram use in depression & the influence of genetic variations on its safety & efficacy,  Ahmed and colleagues reviewed and discussed single nucleotide polymorphisms associated with the safety and efficacy of anti-gout medications, while Haroon et al., compiled, reviewed and discussed the studies showing the genetic influence on Losartan's antihypertensive and uricosuric actions.